Geode Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $485M | Buy |
5,379,525
+145,691
| +3% | +$13.4M | 0.03% | 450 |
|
|
2025
Q4 | $469M | Buy |
5,233,834
+36,611
| +0.7% | +$3.47M | 0.03% | 453 |
|
|
2025
Q3 | $510M | Buy |
5,197,223
+72,447
| +1% | +$7.18M | 0.03% | 425 |
|
|
2025
Q2 | $465M | Buy |
5,124,776
+69,485
| +1% | +$6.72M | 0.03% | 428 |
|
|
2025
Q1 | $570M | Buy |
5,055,291
+178,229
| +4% | +$19.1M | 0.04% | 356 |
|
|
2024
Q4 | $514M | Sell |
4,877,062
-2,323
| -0% | -$249K | 0.04% | 384 |
|
|
2024
Q3 | $525M | Buy |
4,879,385
+125,852
| +3% | +$13.7M | 0.04% | 364 |
|
|
2024
Q2 | $514M | Buy |
4,753,533
+3,748
| +0.1% | +$442K | 0.05% | 346 |
|
|
2024
Q1 | $625M | Buy |
4,749,785
+146,801
| +3% | +$18.3M | 0.06% | 306 |
|
|
2023
Q4 | $559M | Buy |
4,602,984
+98,675
| +2% | +$11M | 0.06% | 307 |
|
|
2023
Q3 | $504M | Buy |
4,504,309
+90,864
| +2% | +$11.5M | 0.06% | 300 |
|
|
2023
Q2 | $641M | Buy |
4,413,445
+98,278
| +2% | +$13.4M | 0.08% | 254 |
|
|
2023
Q1 | $556M | Buy |
4,315,167
+96,028
| +2% | +$12.1M | 0.07% | 275 |
|
|
2022
Q4 | $537M | Buy |
4,219,139
+95,972
| +2% | +$11.1M | 0.08% | 267 |
|
|
2022
Q3 | $431M | Buy |
4,123,167
+95,058
| +2% | +$10.4M | 0.07% | 295 |
|
|
2022
Q2 | $422M | Buy |
4,028,109
+96,027
| +2% | +$11.4M | 0.06% | 303 |
|
|
2022
Q1 | $502M | Buy |
3,932,082
+75,448
| +2% | +$9.09M | 0.06% | 298 |
|
|
2021
Q4 | $474M | Buy |
3,856,634
+36,814
| +1% | +$4.82M | 0.06% | 318 |
|
|
2021
Q3 | $541M | Buy |
3,819,820
+94,500
| +3% | +$13.9M | 0.07% | 262 |
|
|
2021
Q2 | $580M | Buy |
3,725,320
+145,655
| +4% | +$23.6M | 0.08% | 243 |
|
|
2021
Q1 | $555M | Buy |
3,579,665
+87,279
| +2% | +$13.5M | 0.08% | 225 |
|
|
2020
Q4 | $521M | Buy |
3,492,386
+68,761
| +2% | +$9.71M | 0.09% | 213 |
|
|
2020
Q3 | $452M | Buy |
3,423,625
+20,519
| +0.6% | +$2.68M | 0.09% | 204 |
|
|
2020
Q2 | $394M | Buy |
3,403,106
+70,576
| +2% | +$8.13M | 0.08% | 225 |
|
|
2020
Q1 | $326M | Buy |
3,332,530
+25,976
| +0.8% | +$3.41M | 0.09% | 217 |
|
|
2019
Q4 | $480M | Buy |
3,306,554
+131,201
| +4% | +$18.1M | 0.1% | 195 |
|
|
2019
Q3 | $423M | Buy |
3,175,353
+152,839
| +5% | +$19.7M | 0.1% | 212 |
|
|
2019
Q2 | $345M | Buy |
3,022,514
+129,108
| +4% | +$15.1M | 0.08% | 246 |
|
|
2019
Q1 | $358M | Buy |
2,893,406
+172,437
| +6% | +$19.6M | 0.09% | 210 |
|
|
2018
Q4 | $274M | Buy |
2,720,969
+211,698
| +8% | +$23.8M | 0.08% | 229 |
|
|
2018
Q3 | $320M | Buy |
2,509,271
+72,759
| +3% | +$8.65M | 0.09% | 221 |
|
|
2018
Q2 | $263M | Buy |
2,436,512
+73,356
| +3% | +$7.98M | 0.08% | 244 |
|
|
2018
Q1 | $250M | Buy |
2,363,156
+122,852
| +5% | +$14.3M | 0.08% | 247 |
|
|
2017
Q4 | $262M | Buy |
2,240,304
+104,623
| +5% | +$11.8M | 0.09% | 229 |
|
|
2017
Q3 | $242M | Buy |
2,135,681
+65,954
| +3% | +$7.61M | 0.09% | 229 |
|
|
2017
Q2 | $258M | Buy |
2,069,727
+93,246
| +5% | +$11.1M | 0.1% | 203 |
|
|
2017
Q1 | $234M | Buy |
1,976,481
+166,878
| +9% | +$18.9M | 0.1% | 218 |
|
|
2016
Q4 | $181M | Buy |
1,809,603
+76,730
| +4% | +$8.22M | 0.08% | 243 |
|
|
2016
Q3 | $218M | Buy |
1,732,873
+77,398
| +5% | +$9.56M | 0.11% | 187 |
|
|
2016
Q2 | $193M | Buy |
1,655,475
+154,180
| +10% | +$17.4M | 0.11% | 202 |
|
|
2016
Q1 | $155K | Buy |
1,501,295
+90,529
| +6% | +$8.76M | 0.08% | 239 |
|
|
2015
Q4 | $140M | Sell |
1,410,766
-23,842
| -2% | -$2.33M | 0.08% | 254 |
|
|
2015
Q3 | $131M | Sell |
1,434,608
-1,549
| -0.1% | -$155K | 0.08% | 260 |
|
|
2015
Q2 | $152M | Buy |
1,436,157
+61,184
| +4% | +$6.77M | 0.09% | 237 |
|
|
2015
Q1 | $157M | Buy |
1,374,973
+49,336
| +4% | +$5.63M | 0.09% | 237 |
|
|
2014
Q4 | $146M | Buy |
1,325,637
+55,921
| +4% | +$5.89M | 0.09% | 242 |
|
|
2014
Q3 | $124M | Sell |
1,269,716
-6,086
| -0.5% | -$599K | 0.08% | 248 |
|
|
2014
Q2 | $129M | Sell |
1,275,802
-42,266
| -3% | -$4.12M | 0.08% | 241 |
|
|
2014
Q1 | $121M | Buy |
1,318,068
+5,069
| +0.4% | +$467K | 0.08% | 249 |
|
|
2013
Q4 | $119M | Buy |
1,312,999
+62,027
| +5% | +$5.37M | 0.08% | 248 |
|
|
2013
Q3 | $99.7M | Buy |
1,250,972
+66,136
| +6% | +$5.21M | 0.08% | 266 |
|
|
2013
Q2 | $86.2M | Buy |
+1,184,836
| New | +$88.6M | 0.08% | 273 |
|
Other funds holding ZBH
VCM
VPM
Geode Capital Management's ZBH Position: Q1 2026 in Review
Geode Capital Management increased its Zimmer Biomet (ZBH) stake by 2.8% in Q1 2026, buying an estimated $13.4M and bringing the position to 5,379,525 shares worth $485M. The position accounts for 0.03% of the portfolio, ranked #450.
Geode Capital Management first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $641M in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Geode Capital Management held 5,379,525 shares of Zimmer Biomet worth $485M as of Q1 2026.
- Geode Capital Management bought 145,691 Zimmer Biomet shares in Q1 2026, an estimated $13.4M.
- Zimmer Biomet made up 0.03% of Geode Capital Management's portfolio in Q1 2026, its #450 holding.
- Geode Capital Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- Geode Capital Management's Zimmer Biomet position peaked at $641M in Q2 2023.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.